XOMA Royalty Corporation — Earnings Quality Grade F
XOMA · Healthcare
Major red flags
Screening Summary
Management Signals
Financial Trends
Revenue & Net Income ($B)
Margins (%)
18-Point Screening
Revenue Quality
DSO surged by 88 days (66 → 153)
Small-cap context: DSO swings on a small revenue base are more often quarterly customer-mix effects than red flags.
AR growth 166.2% exceeds revenue growth 14.1%
Revenue 14.1%, CFFO 120.9%. Cash follows revenue
Expense Quality
No material inventory
CapEx growth 103525.0% is >2x revenue growth 14.1%
Insufficient data
Insufficient data
Cash Flow Quality
CFFO < Net Income for 3 consecutive years
Small-cap context: Small-cap CFFO/NI often diverges from working-capital swings, not necessarily manipulation.
FCF is negative ($-0.0B)
Accruals ratio = 10.6%. Exceeds 10%
Cash $0.1B covers 63% of debt $0.1B
Balance Sheet Health
Goodwill+Intangibles $0.0B = 53% of equity. Over 50%
Interest coverage = 0.9x (<2x). Financial stress
Other assets grew 480.6% vs revenue 14.1%
No write-off data
Acquisition Risk
FCF after acquisitions negative for 3 years
Small-cap context: A single acquisition on a small balance sheet can trip serial-acquirer logic.
Goodwill+Intangibles surged 73% YoY
Manipulation Score
Insufficient data
Portfolio monitoring
Monitor XOMA continuously
The full checks and model details are free to read. Use Watchlist to track your holdings; Pro adds automatic quarterly rescoring, risk-event email alerts, scans up to 50 tickers, and export workflows.
Altman Z-Score
Generated from public financial data using forensic accounting frameworks. Not investment advice. Data: Yahoo Finance · 2026-04-25